Linked Life Data

6178593

Source:http://linkedlifedata.com/resource/pubmed/id/6178593

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1982-9-24
pubmed:abstractText
Serial measurements of serum ferritin have been assessed as an additional marker in a study of 12 patients with germ cell tumours. The standard markers, serum AFP and beta HCG, were also assessed serially. During treatment elevated levels of serum ferritin were detected in 10 patients, elevated AFP in 10 patients and elevated beta HCG in 6 patients. A poor prognosis was associated with persistently raised serum ferritin and either, or both, elevated AFP and beta HCG levels. Decreasing levels of serum ferritin indicated favourable response to treatment; rising values were associated with recurrence or dissemination of tumour. Even if serum ferritin cannot be classed specifically as a tumour product, it may be useful in the early detection of residual or recurrent tumour.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0277-5379
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
261-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Serum ferritin as a third marker in germ cell tumours.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't